Best TB 500 peptide, chemically consisting of an acetylated short peptide chain, has a molecular formula of C38H68N10O14, CAS 885340-08-9, and a molecular weight of 889.01 Da. Its core sequence is Ac-LKKTETQ (N-acetylated-leucine-lysine-lysine-threonine-glutamic acid-threonine-glutamine). As a synthetic polypeptide, it has garnered widespread attention in the biomedical field. Composed of a specific amino acid sequence, it exhibits unique biological functions by binding to actin and regulating cell signaling pathways. In terms of tissue repair, it promotes cell migration and proliferation, accelerating wound healing. Whether it's skin trauma in animal experiments or muscle and tendon injuries caused by sports injuries, topical application can significantly shorten the repair time and enhance the quality of repair. Regarding safety, long-term use at low doses has not shown severe adverse reactions in animal experiments, but high doses may trigger immunogenic reactions. Its production quality varies, posing risks such as infection. Please carefully evaluate before use.
Our product form
TB 500 COA
The common synthesis method for best TB 500 peptide (synthetic molecule of thymosin beta 4 active region) primarily relies on solid-phase peptide synthesis (SPPS) technology, and can incorporate liquid-phase synthesis techniques to handle complex fragments, while optimizing its stability and activity through chemical modification. The specific methods and instructions are as follows:
Method 1: Solid-phase peptide synthesis (SPPS) technology
Solid Phase Peptide Synthesis (SPPS) technology represents a significant breakthrough in the field of modern peptide and protein chemistry. It was first proposed by American biochemist Bruce Merrifield in 1963 and earned him the Nobel Prize in Chemistry in 1984. This technology simplifies the process of peptide synthesis by attaching amino acids one by one to a solid phase carrier (such as resin) to gradually build the polypeptide chain, thereby accelerating the rapid development of peptide drugs, vaccines, and protein research. As a biologically active peptide molecule, TB 500 peptide is often synthesized using SPPS technology. The following provides a detailed elaboration on the technical principle, key steps, optimization strategies, as well as challenges and solutions.
Technical principle of SPPS
The core idea of SPPS technology is to immobilize the C-terminus of the polypeptide chain on a solid phase support (such as polystyrene resin) and extend the peptide chain by gradually adding amino acids. Each reaction step includes three key steps: deprotection, coupling, and washing:
Deprotection:
Removing the amino acid's amino protecting group (such as Fmoc or Boc) to expose the amino group for subsequent reactions.
Coupling:
The activated protected amino acid is connected to the peptide chain through a condensation reaction, forming a new peptide bond.
Washing:
Remove unreacted reagents and by-products to ensure the purity of the reaction system.
This process is repeated until all amino acids are connected in the predetermined order, and finally the target polypeptide is cleaved from the resin.
Key steps of SPPS for best TB 500 peptide
1. Resin selection and pretreatment
The choice of resin is crucial for the success rate of peptide synthesis and the properties of the final product. For the synthesis of TB 500 peptide, commonly used resins include Wang resin and Rink Amide resin:
Wang resin: suitable for synthesizing peptides with a carboxyl group at the C-terminus, featuring an acid-sensitive linker for easy subsequent cleavage.
Rink Amide resin: used for synthesizing peptides with an amide at the C-terminus. Its linker is stable to acid and requires cleavage with special reagents.
Resin pretreatment involves steps such as removing protective groups and activating functional groups to ensure that the resin is in its optimal synthetic state.
2. Amino acid protection and activation
In SPPS, the amino and carboxyl groups of amino acids need to be protected with protecting groups to prevent side reactions. Commonly used amino protecting groups include Fmoc and Boc:
Fmoc protecting group: It can be removed using a weakly alkaline solution (such as 20% piperidine/DMF), making it suitable for synthesis under mild conditions.
Boc protecting group: It needs to be removed using an acidic solution (such as TFA/DCM), and is suitable for syntheses requiring strong acid conditions.
The carboxyl protecting group is typically chosen as an ester group or amide group. The selection of the activating agent is equally crucial. Commonly used activators include DIC, HBTU, HCTU, etc., which can promote the formation of peptide bonds and enhance synthesis efficiency.
3. Condensation reaction and deprotection
The condensation reaction is the core step in SPPS, connecting activated amino acids to the peptide chain. Reaction conditions (such as temperature, time, and reagent ratio) need to be optimized based on the specific amino acid and resin type. For example, for amino acids that are difficult to synthesize (such as β-branched amino acids), heating assistance or extending the reaction time can be used to improve the coupling efficiency.
The deprotection step necessitates precise control over the concentration of the deprotecting reagent and the reaction time to prevent excessive deprotection or the occurrence of side reactions. For instance, when using piperidine to remove the Fmoc protecting group, UV monitoring is required to determine the deprotection efficiency and adjust the number of treatments and duration.
4. Cleavage and removal of side chain protecting groups
Once all amino acids are connected in the correct sequence, the polypeptide needs to be cleaved from the resin and the side chain protecting groups removed. This step is typically carried out using strong acids (such as TFA) or strong bases (such as sodium hydroxide) to cleave the polypeptide and remove the side chain protecting groups simultaneously. The cleavage conditions need to be optimized based on the type of resin and the properties of the protecting groups to avoid degradation of the peptide chain or the occurrence of side reactions.
5. Peptide purification and analysis
The crude peptide product after cleavage needs to be purified by reverse-phase high-performance liquid chromatography (RP-HPLC) to remove impurities and unreacted amino acids. The purification conditions (such as mobile phase composition, flow rate, and column temperature) need to be optimized based on the properties of the peptide. The purified peptide needs to undergo structural and purity analysis by methods such as mass spectrometry (MS) and ultraviolet absorption spectroscopy (UV) to ensure that it meets the experimental or application requirements.
SPPS technology optimization strategy
To enhance the synthesis efficiency and purity of TB 500 peptide, the following optimization strategies can be adopted:
Sequence analysis and prediction:
Use software to predict potential difficult areas (such as β-branch amino acids, hydrophobic regions) during the synthesis process, and adjust the reaction conditions in advance.
01
Double coupling and extended reaction time:
For amino acids that are difficult to synthesize, double coupling or extending the reaction time can be employed to enhance the coupling efficiency.
02
Heating assistance:
Heating can accelerate the reaction rate and improve synthesis efficiency, but attention should be paid to the impact of temperature on the sequence.
03
Blocking treatment:
Permanently blocking unreacted amino groups after the coupling reaction to reduce the formation of defective products and aid the purification process.
04
Green solvent substitution:
Using green solvents such as DMSO and ethyl lactate to replace traditional solvents (such as DMF) to reduce environmental pollution.
05
Technical Challenges and Solutions of SPPS
Despite the numerous advantages of SPPS technology, there are still some challenges when synthesizing complex peptides such as best TB 500 peptide:
Module title
Difficulty in synthesizing long peptide chains: As the length of the peptide chain increases, synthesis efficiency may decrease, leading to a reduction in the yield of the target polypeptide. Solutions include optimizing reaction conditions, using efficient activators, and adopting segmented synthesis strategies.
Side reaction risks: Side reactions such as cyclization and isomerization may occur during the deprotection or coupling steps. Solutions include selecting appropriate protecting groups and activators, controlling reaction conditions, and using additives to reduce side reactions.
Solubility issues of hydrophobic peptides: The aggregation of strongly hydrophobic amino acids may lead to solubility issues during the synthesis process. Solutions include adjusting the amino acid sequence, increasing the proportion of polar amino acids, and using special solvents.
Oxidation of labile amino acids: Peptides containing labile amino acids such as Cys, Met, or Trp are prone to oxidative degradation. Solutions include using deoxygenated buffers, slowly flowing nitrogen or argon gas before capping to reduce oxidation, and storing at low temperatures.
Method 2: Liquid-phase synthesis technology (auxiliary method)
In the field of peptide synthesis, solid-phase synthesis technology holds a dominant position in large-scale peptide preparation due to its advantages such as relatively simple operation and ease of automation. However, the world of peptides is rich and diverse, and there are some extremely complex peptide fragments, which are like formidable fortresses that solid-phase synthesis technology cannot overcome. At this time, liquid-phase synthesis technology, with its unique charm and powerful capabilities, becomes a crucial auxiliary method to solve these problems.
1. Application scenarios
When faced with certain peptide fragments with special structures, solid-phase synthesis often encounters difficulties. For example, peptides containing multiple consecutive β-pleated sheets often encounter difficulties in the connection reaction between amino acids on the solid-phase support due to steric hindrance, resulting in low reaction efficiency and low product purity. Another example is peptides containing special amino acids, such as those with complex side chain modifications, non-natural amino acids, or amino acids with optical isomerism.
Solid-phase synthesis faces significant challenges in controlling the accurate connection and stereochemical configuration of these special amino acids. For these complex peptide fragments that are difficult to obtain through solid-phase synthesis, liquid-phase synthesis technology has demonstrated great potential.
Liquid-phase synthesis typically plays a significant role in scenarios demanding small-scale production and high purity. Small-scale synthesis allows researchers to exercise finer control over reaction conditions, enabling real-time monitoring and adjustment of each step.
For instance, the reaction temperature can be precisely controlled to fluctuate within a narrow range, ensuring that the reaction proceeds at its optimal temperature. The concentration and ratio of reaction reagents can be accurately adjusted to avoid side reactions caused by excess or insufficient reagents. Additionally, for peptides with extremely high purity requirements, such as those used as key active ingredients in drug development or as probes in biomedical research, liquid-phase synthesis can optimize reaction conditions and purification processes to obtain high-purity target products that meet strict quality standards.
Furthermore, liquid-phase synthesis can be ingeniously combined with solid-phase synthesis to form a segmented synthesis strategy. This strategy resembles a relay race, breaking down complex polypeptide chains into several relatively simple and easily synthesizable fragments. Initially, the convenience of solid-phase synthesis in synthesizing simple fragments on a large scale is leveraged to quickly and efficiently prepare these fragments.
Subsequently, the flexibility of liquid-phase synthesis in handling complex fragments and precise ligation is employed to connect the individual fragments into a complete polypeptide chain through specific chemical methods. This segmented synthesis approach fully utilizes the advantages of both synthesis techniques, significantly enhancing the success rate of complex polypeptide synthesis.
2. Key steps:
Fragment synthesis: Synthesize different fragments of polypeptides separately.
Fragment ligation: Joining fragments into a complete polypeptide chain through chemical methods such as thioester exchange and native chemical ligation.
3. Advantages:
Capable of handling complex structures that are difficult to achieve in solid-phase synthesis.
It can enhance the success rate of synthesis and reduce the cost of synthesis.
Hot Tags: best tb 500 peptide, China best tb 500 peptide manufacturers, suppliers, Best Ghk Cu Peptide Injection, Ghk cu Gummies, Ghk cu Peptide Capsule, Nad Peptide Injection, TB 500 Peptide Tablets, The Best Glutathione Injection
